Related Experiment Videos
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy
1Department of Neurology, Stanford University Medical Center, CA 94305-5235.
Headache
|April 1, 1991
Summary
Abortive anti-migraine drugs, like sumatriptan, are 5-HT1D receptor agonists that inhibit adenylate cyclase. This action may explain their effectiveness in treating migraines.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Migraine treatment involves abortive and prophylactic agents.
- The 5-HT1D receptor is a potential target for migraine therapies.
- Understanding drug-receptor interactions is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the interaction of abortive and prophylactic anti-migraine agents with 5-HT1D receptors.
- To determine if 5-HT1D receptor agonism underlies the efficacy of abortive migraine medications.
Main Methods:
- Radioligand binding assays were used to measure drug affinities for 5-HT1D receptors in bovine caudate.
- Adenylate cyclase assays in bovine substantia nigra assessed the biochemical effects of these agents.
Main Results:
- Abortive agents (5-hydroxytryptamine, ergotamine, dihydroergotamine, sumatriptan) showed high affinity (4.0-34 nM) for 5-HT1D receptors.
- Prophylactic agents (methysergide, amitriptyline, (-)propranolol, verapamil) exhibited lower affinities (46-11,000 nM).
- Abortive agents dose-dependently inhibited forskolin-stimulated adenylate cyclase activity, indicating 5-HT1D receptor agonism.
Conclusions:
- The findings support the hypothesis that abortive anti-migraine agents act as 5-HT1D receptor agonists.
- This 5-HT1D receptor agonistic activity is a likely mechanism for their anti-migraine efficacy.